aminophylline has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, A; Chiriboga-Hurtado, J; Currlin, SW; Dotson, CD; Gorbatyuk, OS; Herzog, H; Hurtado, MD; La Sala, M; Sergeyev, VG; Spegele, M; Waler, NJ; Zolotukhin, S | 1 |
| Cao, F; Chen, X; Kim, TH; Ma, N; Niu, G; Sun, Z; Tong, G | 1 |
2 other study(ies) available for aminophylline and glucagon-like peptide 1
| Article | Year |
|---|---|
Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion.
Topics: alpha-MSH; Aminophylline; Animals; Conditioning, Psychological; Eating; Extracellular Signal-Regulated MAP Kinases; Feeding Behavior; Gene Expression Regulation; Glucagon-Like Peptide 1; Humans; Iodine Isotopes; Male; Mice; Mice, Inbred C57BL; Oxytocin; Peptide Fragments; Peptide YY; Proto-Oncogene Proteins c-fos; Saliva; Satiation; Tyrosine 3-Monooxygenase; Vasopressins | 2013 |
PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.
Topics: Aminophylline; Animals; Atropine; Blotting, Western; Cardiovascular Agents; Disease Models, Animal; Drug Combinations; Exenatide; Glucagon-Like Peptide 1; Heart; Heart Function Tests; Histocytochemistry; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Nitroglycerin; Papaverine; Peptides; Phenobarbital; Survival Analysis; Treatment Outcome; Venoms | 2015 |